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Summary Using a panel of DNA probes for hypervariable DNA regions we screened 52 gastrointestinal
carcinomas for clonal allele losses on chromosomes 1, 5, 7, 12, 16 and 17. A total of 24/35 informative cases
of colorectal cancers showed loss of constitutional heterozygosity at a locus on chromosome 17p, while 9/31
cases informative for a locus on 5q showed allele loss. Loss of sequences at 5q was linked to allele loss at 17p
with a single exception. In gastric cancers loss of heterozygosity most frequently occurred at lq (5/10
tumours) and at 12q (6/lltumours). Gastrointestinal tumours show consistent chromosomal losses and the
loci involved are different in gastric and colorectal cancers.
Many human neoplasias show consistent chromosomal
abnormalities (Yunis, 1983). However, karyotyping of solid
tumours has been hampered by technical problems of
obtaining satisfactory mitoses. With the rapid increase in the
numbers of mapped polymorphic DNA markers the
molecular analysis of tumours has proved to be a powerful
alternative approach for the detection of clonal allele losses
in cancer DNA. This is exemplified by the inherited and
sporadic forms of retinoblastoma (Cavenee et al., 1985) and
other tumours (Ali et al., 1987; Brauch et al., 1987). The
search for regions of the human genome with consistent
deletions in tumours appears to be a rational approach to the
identification of tumour suppressor genes or anti-oncogenes
(Knudson, 1985; Friend et al., 1988).
Mutational activation of ras-oncogenes (Bos et al., 1987;
Forrester et al., 1987) and somatic allele loss on the long
arm of chromosome 5 (Solomon et al., 1987), on the short
arm of chromosome 17 (Fearon et al., 1987) and on
chromosome 18 (Law et al., 1988) have been shown to be
consistent genetic alterations in the development of
colorectal cancers (Vogelstein et al., 1988). However,
previous reports on the molecular analysis of stomach
cancers have been scarce (Motomura et al., 1988; Wada et
al., 1988) and no comparison on the molecular analysis of
non-random allele losses in these two groups of tumours has
been reported.
Here we present a comparative molecular analysis of 52
gastrointestinal cancers by Southern blot hybridisation of
constitutional and tumour DNA with a panel of highly
polymorphic locus-specific DNA markers specific for
particular chromosomal regions. The vast majority of
individuals can be expected to be constitutionally
heterozygous at these loci and, therefore, informative for
analysis (Nakamura et al., 1987; Wong et al., 1987).
Materials and methods
Subjects
Twelve patients with gastric adenocarcinoma and 40 patients
with colorectal adenocarcinoma of the sporadic type (with a
negative family history for colonic neoplasia) were studied.
In each case samples of tumour and normal gastrointestinal
tissue were obtained fresh from specimens removed at
surgery. A sample of peripheral venous blood was also
collected. In four patients with colorectal cancers, colonic
adenomas were available for analysis. For comparison, six
cases of breast cancer and five cases of Crohn's disease (the
samples taken from both normal mucosa and inflammatory
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lesions) were included. Necrotic and non-neoplastic tissue
was removed from tumour samples as completely as possible.
For each tumour sample, microscopic slides were made from
the same tissue sections taken for DNA extraction.
Histopathological diagnosis was made by analysis of these
slides, and for each individual tumour sample the tumour
cells comprise more than 60% of these cells.
DNA analysis
High molecular weight DNA was extracted from blood and
tissues according to standard procedures (Maniatis et al.,
1982), digested with the appropriate restriction enzymes
(Table I) and the fragments separated by electrophoresis in
1% (w/v) agarose gels. The digests of tumour DNA were
electrophoresed in tracks adjacent to digests of the
corresponding constitutional DNA from blood and normal
gastrointestinal mucosa. Fractionated DNA was transferred
to nylon filters (Hybond-N, Amersham, UK) by Southern
blotting and hybridised to DNA probes radiolabelled with
32P-deoxycytidine triphosphate by the random hexamer
priming method (Feinberg & Vogelstein, 1983). After
hybridisation the filters were washed under stringent
conditions and subjected to autoradiography between
intensifier screens for one to four days at -70°C. Filters
were hybridised with a different DNA probe after elution of
the previous probe according to the manufacturer's
instructions.
DNA probes
Digests of normal and tumour DNA from each case were
hybridised consecutively to a panel of tandem repetitive
DNA probes specific for hypervariable chromosomal regions
(HVRs) (see Table I).
Cases were considered informative for analysis at a given
locus if the constitutional DNA showed heterozygosity, i.e.
two detectable alleles. Tumour DNA was studied for loss of
alleles present in the corresponding constitutional DNA. A
phenomenon seen in Southern blot hybridisation using
hypervariable DNA probes is that the shorter alleles tend to
be less intense than the larger ones. This is related to the
number of repeating units available for hybridisation in the
shorter alleles. In view of this phenomenon, any intensity
difference between two alleles in tumour DNA should be
interpreted by comparison with the band patterns in
constitutional DNA and the difference clearly discernable, as
illustrated in Figures 2 and 3. Furthermore, densitometer
analysis to determine the ratios of hybridisation of alleles in
the normal and tumour DNA would not be practical and it
would be more realistic to correct for differences in DNA
loading by rehybridising the filters with other non-
hypervariable DNA probes, as carried out for the cases here.
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Table I. Molecular analysis of gastric and colorectal cancers with chromosome specific HVR probes.
Probe AMSIa AMS32' pMUCJOb¢c AMS8a pAg3d )MS31a )MS43a 3'ocHVRe pYNZ22f
Locus lp3.3-3.5 Iq4.2-4.3 1q2.1-2.4 5q3.5-ter 7q3.3-ter 7p2.2-ter 12q2.4-ter 16pl2-pter 17p
Enzyme HinfI AluI HinfI/EcorRI HinfI HinfI HinfI HinfI HinfI SstI
Gastric cancer 12 12 12 12 12 12 12 12 12
Informative Total 9 6 10 10 9 10 11 5 10
Loss 3 1 5 1 0 0 6 0 2
Gain 0 0 0 0 0 0 0 0 0
Not informative 3 2 2 2 2 1 0 7 1
Not done 0 4 0 0 1 1 1 1 1
Colorectal cancer 40 40 40 40 40 40 40 40 40
Informative Total 37 34 27 31 32 35 35 18 35
Loss 6 4 3 9 0 1 3 0 24
Gain 2 1 0 0 2 4 0 0 0
Not informative 1 0 11 7 6 2 3 20 5
Not done 2 6 2 2 2 3 2 2 0
References: aWong et al. (1987); bSwallow et al. (1987a); cSwallow et al. (1987b); dwong et al. (1986); eJarman et al. (1986); 'Nakamura
et al. (1987).
In all cases the loss of alleles became obvious on over-
exposure of the autoradiograph with respect to the other
bands.
Statistical analysis was performed employing x2 tests in
four-fold tables.
Results
Constitutional heterozygosity at the loci screened by our
panel of HVR probes (ip, lq, 5q, 7p, 7q, 12q, 16p, 17p) was
present in 75-100% of the cases except for the a-globin 3'
HVR probe which detected heterozygosity in only 46% of
the cases (Table I).
In all the cases, the pattern of alleles detected by a
particular probe in constitutional DNA from leukocytes was
identical to that from the corresponding gastrointestinal
mucosa. No allele loss or any other changes were observed
in DNA from inflammatory lesions of the five cases of
Crohn's disease, the six cases of breast cancer and the four
colorectal adenomas.
Gastric cancers
The majority of the patients with gastric cancers were
constitutionally heterozygous at seven of the nine loci
Table II Allele losses in normal tissue and tumour tissue in cases of
gastric cancer.
Patient Alleles present in normal and tumour tissue
Probe IMSJ AMS32 pMUCJO 2MS43
Locus lp33-35 Iq42-43 Iq21-24 12q24-ter
Source of DNA C T C T C T C T
1 2 2 2 2 2 2 2 1
2 2 1 1 - 2 1 2 1
3 1- 2 1 2 1 2 1
4 1 2 2 2 2 2 2
5 2 2 1 - 1 - 2 2
6 1 - ND 2 2 ND
7 2 2 2 2 2 1 2 1
8 2 2 2 2 2 1 2 2
9 2 2 2 2 2 2 2 2
10 2 1 ND 1 - 2 1
11 2 2 ND 2 2 2 2
12 2 1 ND 2 1 2 1
The presence of two alleles in normal tissue indicates consti-
tutional heterozygosity at a particular locus. If the tumour has
sustained a loss, only one of the two alleles can be detected.
Constitutionally homozygous cases with only one allele in DNA
from normal tissue are uninformative for the analysis of allele losses
(the genotype of the tumour is indicated by a blank in these cases).
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examined (Table I and Figure 1). The most consistent
somatic losses were observed at 1q (5 of 10 cases) detected
by the probe pMUC1O and at 12q (6 of 11 cases) detected
by the probe AMS43 (Table II, Figure 2).
Only a few cases of colorectal cancers showed somatic
losses at these loci. The differences in the frequency of losses
between gastric and the colorectal cancers at these loci is
statistically significant (P<0.05 for pMUCl0; P<0.02 for
AMS43). In contrast to the colorectal cancers, gastric
tumours showed only occasional losses for sequences on 17p
(2/10 informative cases) and on 5q (1/10 informative cases)
(P<0.005).
Colorectal cancers
Loss of heterozygosity was observed in tumour DNA in five
of the six chromosomes examined (1, 5, 7, 12 and 17) with
frequencies ranging from 3 to 69% of the informative cases
(Table I and Figure 1). Twenty-four of the 35 tumours
(69%) demonstrated a loss of one allele on the short arm of
chromosome 17 as detected by the probe pYNZ22 (Figure
3). This loss was significantly more frequent than losses
observed with the other probes (P<0.02). Nine of 31 (29%)
informative cases had a loss of heterozygosity on the long
arm of chromosome 5 as detected by the probe 1MS8
(Figure 3). Twenty-six cases were informative for both
pYNZ22 (17p) and AMS8 (5q); 13 demonstrated a loss of
heterozygosity for 17p but were normal for 5q whereas nine
demonstrated a loss of heterozygosity for 5q of which eight
were accompanied by allele loss at 17p.
.Clonal allele loss for 17p and 5q sequences in colorectal
carcinomas were noted in all tumour stages with no
statistically significant difference between the early (Dukes A
and B) and late (Dukes C and D) stages.
Other findings
The specificity of the loss of heterozygosity for sequences on
chromosomes lq and 12q in gastric cancers and for
sequences on chromosomes 17p and 5q in colorectal cancers
was emphasised by the observation that none of these
sequences were lost in the six cases of breast cancer. One
colorectal cancer showed an allele loss on chromosome 7p
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and no losses were observed for colorectal cancers on 7q and
16p. Six cases of colonic cancer and one case of stomach
cancer had an intensity gain of one allele on chromosome 7.
Several of the probes detected new mutant bands in the
tumour DNA, the highest mutation rate was shown by the
probe AMS1 (6/25 cancers, 11.5%). The rates of spontaneous
mutations at HVRs in these tumour tissues appear to be
similar to those observed in the germline (Jeffreys et al.,
1988). The high incidence of somatic mutations is probably
related to the high turnover of gastrointestinal epithelium. A
detailed analysis of the somatic mutation rate at HVRs in
human tumours will be presented elsewhere (Armour et al.,
1989).
Discussion
Using a panel of locus-specific minisatellite probes for HVRs
we have been able to analyse the majority of the cases
collected for this study. The high rates of heterozygosity (75-
100%) at these hypervariable regions make these DNA
probes particularly valuable for the screening of dispersed
regions of human tumour DNA for somatic losses' of
localised chromosomal sequences. Furthermore, since the
majority of these HVRs can be detected by the same
restriction enzyme, e.g. HinfI, the filters can be re-
hybridised with different probes without the need for
different restriction enzyme digests.
Evidence is accumulating that malignant tumours may be
generated by recessive mutations in somatic cells which are
unmasked by a loss of the unaffected gene on the
homologous chromosome (Harris, 1986). It appears that in
various types of human cancers loss of heterozygosity
consistently occurs at particular chromosomal loci.
Previous cytogenetic studies of stomach carcinomas have
demonstrated non-random losses of chromosomes 1, 7 and
12 (Ferti-Passantonopoulou et al., 1987; Sandberg, 1980).
Now using DNA probes we demonstrate at a molecular level
that loss of alleles in stomach cancers is particularly frequent
on chromosomes lq and 12q. Further studies, including a
precise mapping of these loci, are warranted. We are aware
of one other report on the study of allele loss in stomach
cancers by a similar approach (Motomura et al., 1988; Wada
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Figure 2 Clonal allele losses in two cases of stomach cancer. In
case 1 a stomach cancer (C) with regional lymph node metastasis
(Mt); DNA was digested with EcoRI and hubridised to the probe
pMUClO which detects an HVR on chromosome lq. The
constitutional DNA from peripheral blood leucocytes (Bi) shows
heterozygosity at this locus which is lost in the tumour (C and
Mt). The faint 10.0 kb band seen in the metastasis (Mt) is due to
the admixture of normal lymph node tissue. In case 2
constitutional DNA from gastric mucosa (M) and blood (Bl) and
tumour DNA from a stomach cancer (C) was digested with
HinfI and hybridised to the probe AMS43 which detects an HVR
on chromosome 12q. Although constitutional DNA (Bl and M)
shows two alleles, the tumour DNA (C) shows only the smaller
9.2kb allele. Allele sizes indicated in kilobases.
2 1
Figure 3 Clonal allele loss -in two cases of colorectal
carcinomas. In case 1 DNA was digested with SstI and
hybridised to the probe pYNZ22 which detects sequences on
chromosome 17p. Lanes Bl-peripheral blood leucocytes DNA; C-
tumour DNA, A-colonic adenoma DNA; M-normal clonic
mucosa DNA. In case 2 DNA was digested with HinfI and
hybridised to the probe AMS8 which detects sequences at 5q.
Lanes Bl, peripheral blood leucocyte DNA; M, normal colonic
mucosa DNA; Cl, DNA from rectal adenocarcinoma; C2, DNA
from sigmoid adenocarcinoma. Both cases demonstrate
constitutional heterozygosity and clearly show clonal allele losses
in the cancer DNAs; in particular, in case 1 loss of
heterozygosity is restricted to cancer DNA while the adenoma
remains normal. Allele sizes are indicted in kilobases.ALLELE LOSS IN GIT CANCER 753
et al., 1988). In this study, isolated losses were demonstrated
at 25 loci on 18 different chromosomes; sequences on lq and
12q were not analysed.
The loss of sequences on chromosome lq detected by the
probe pMUCIO is particularly interesting. pMUCIO detects
a highly polymorphic locus coding for a family of mucin-
type glycoproteins abundant in normal epithelial tissues,
body fluids and tumours of epithelial origin (Swallow et al.,
1987a,b; Gendler et al., 1987). It is the only hypervariable
DNA locus in human DNA known to be transcribed and
translated; moreover the expressed gene products show the
same polymorphisms. While the present data are not
sufficient to speculate as to how recessive mutations at this
locus might influence the evolution of a malignant stomach
tumour, the demonstration of clonal losses at a locus known
to express tumour-associated antigens is certainly intriguing.
Moreover, this chromosomal loss may be interstitial in some
tumours; two gastric cancers (numbers 7 and 8, Table II)
demonstrate clonal loss with pMUC1O which is localised to
lq2.1-2.4 but not with the probe AMS32 which is localised
to lq4.2-4.3.
In colorectal cancer clonal loss of DNA sequences
frequently and specifically occurs on chromosome 17p, as
confirmed in this study, and on chromosome 18 (Law et al.,
1988). Since a substantial proportion of sporadic colorectal
cancers also demonstrates allele losses at 5q22 (Solomon et
al., 1987), a region known to contain the gene for familial
adenomatous polyposis (Bodmer et al., 1987), it has been
suggested that the loss of sequences at this locus may be a
critical step in the evolution of colorectal tumours. Our data
show that loss of heterozygosity at Sq rarely occurs as an
isolated phenomenon in colorectal carcinomas, but rather in
combination with losses on chromosome 17p, findings rather
similar to those of Law et al. (1988). In this study, it was
found that of 31 colorectal cancers informative for chromo-
some 5 markers, six showed loss of heterozygosity at 5q with
co-existing losses at chromosomes 17p and 18. As shown
here and by others (Fearon et al., 1987; Okamoto et al.,
1988) loss of heterozygosity in loci other than 18, 17p and
5q are only rarely involved in colonic cancers.
The precise localisation of the clonal allele losses to
particular chromosomal regions will require further mapping
studies which should be greatly helped by the increasing
number of suitably mapped polymorphisms in the human
genome (Donnis-Keller et al., 1987). The construction of
primary genetic maps for individual chromosomes should
also help to determine if some of these losses involve all of
one chromosome or were localised to specific regions of
certain chromosomes. In addition to gene mapping, future
studies should focus on .cloning the putative recessive
oncogenes and anti-oncogenes involved in the development
of malignant tumours as demonstrated in retinoblastoma
(Friend et al., 1987). Little is also known about the
prognostic and epidemiological significance of these clonal
chromosomal deletions. It has been demonstrated that non-
random cytogenetic abnormalities may be of prognostic
significance as best exemplified by the haematological
neoplasms (Yunis et al., 1984), and in certain solid tumours
allelic deletions of c-rasHa and c-myc sequences have been
shown to correlate with tumour progression and metastasis
(Yokota et al., 1986).
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